Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial

Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the AZD8701 study, including its design, eligibility criteria, outcomes, locations, and data-sharing information, instead of a 403 error page.
    Difference
    73%
    Check dated 2026-11-08T14:55:31.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site's displayed revision changed from v3.7.2 to v3.8.0, while the study page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:57:48.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with both terms appearing during the transition.
    Difference
    1%
    Check dated 2026-10-25T16:56:34.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-18T22:29:12.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:26:26.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of the study content, replacing the study details with a generic error screen. This blocks access to the trial information and navigation, effectively making the page unusable for viewing the study record.
    Difference
    21%
    Check dated 2026-09-20T20:27:04.000Z thumbnail image

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.